Transporter–enzyme interplay and the hepatic drug clearance: what have we learned so far?
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Transporter–enzyme interplay and the hepatic drug clearance: what have we learned so far?
Authors
Keywords
-
Journal
Expert Opinion on Drug Metabolism & Toxicology
Volume 16, Issue 5, Pages 387-401
Publisher
Informa UK Limited
Online
2020-04-01
DOI
10.1080/17425255.2020.1749595
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- In Vitro-In Vivo Extrapolation and Hepatic Clearance-Dependent Underprediction
- (2019) Christine M. Bowman et al. JOURNAL OF PHARMACEUTICAL SCIENCES
- Quantitative investigation of hepatobiliary transport of [11C]telmisartan in humans by PET imaging
- (2019) Maeda Kazuya et al. Drug Metabolism and Pharmacokinetics
- A Novel Unified Approach to Predict Human Hepatic Clearance for Both Enzyme- and Transporter-Mediated Mechanisms Using Suspended Human Hepatocytes
- (2019) Keith A. Riccardi et al. DRUG METABOLISM AND DISPOSITION
- Mechanistic Evaluation of the Complex Drug-Drug Interactions of Maraviroc: Contribution of Cytochrome P450 3A, P-Glycoprotein and Organic Anion Transporting Polypeptide 1B1
- (2019) Emi Kimoto et al. DRUG METABOLISM AND DISPOSITION
- The Presence of a Transporter-Induced Protein Binding Shift: A New Explanation for Protein-Facilitated Uptake and Improvement for In Vitro-In Vivo Extrapolation
- (2019) Christine M. Bowman et al. DRUG METABOLISM AND DISPOSITION
- Emerging Role of Organ‐on‐a‐Chip Technologies in Quantitative Clinical Pharmacology Evaluation
- (2019) Nina Isoherranen et al. CTS-Clinical and Translational Science
- Effect of hepatic OATP 1B inhibition and chronic kidney disease on the pharmacokinetics of a liver‐targeted glucokinase activator: A model‐based evaluation
- (2019) Arthur Bergman et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Integrated in vitro models for hepatic safety and metabolism: evaluation of a human Liver-Chip and liver spheroid
- (2019) Alison J. Foster et al. ARCHIVES OF TOXICOLOGY
- Clopidogrel as a Perpetrator of Drug–Drug Interactions: A Challenge for Quantitative Predictions?
- (2019) Manthena V.S. Varma et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Liver Microphysiological Systems for Predicting and Evaluating Drug Effects
- (2019) Alexandre J.S. Ribeiro et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- PET Imaging of [ 11 C]Rosuvastatin Hepatic Concentrations and Hepatobiliary Transport in Humans in the Absence and Presence of Cyclosporine A
- (2019) Sarah Billington et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Quantitative contribution of six major transporters to the hepatic uptake of drugs: 'SLC-phenotyping' using primary human hepatocytes
- (2019) Yi-an Bi et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- The potential protein-mediated hepatic uptake: discussion on the molecular interactions between albumin and the hepatocyte cell surface and their implications for the in vitro-to-in vivo extrapolations of hepatic clearance of drugs
- (2019) Michel Bteich et al. Expert Opinion on Drug Metabolism & Toxicology
- On the potential of in vitro organ-chip models to define temporal pharmacokinetic-pharmacodynamic relationships
- (2019) Christopher W. McAleer et al. Scientific Reports
- Quantitative Translation of Microfluidic Transporter in Vitro Data to in Vivo Reveals Impaired Albumin-Facilitated Indoxyl Sulfate Secretion in Chronic Kidney Disease
- (2019) Thomas K. van der Made et al. MOLECULAR PHARMACEUTICS
- Quantitative Assessment of Elagolix Enzyme-Transporter Interplay and Drug–Drug Interactions Using Physiologically Based Pharmacokinetic Modeling
- (2019) Manoj S. Chiney et al. CLINICAL PHARMACOKINETICS
- PBPK models for evaluating membrane transporter mediated DDIs: Current capabilities, case studies, future opportunities and recommendations
- (2019) Kunal Taskar et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Quantitative Proteomics and Mechanistic Modeling of Transporter‐mediated Disposition in Non‐Alcoholic Fatty Liver Disease
- (2019) Anna Vildhede et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Predicting Human Clearance of Organic Anion Transporting Polypeptide Substrates Using Cynomolgus Monkey: In Vitro–In Vivo Scaling of Hepatic Uptake Clearance
- (2018) Tom De Bruyn et al. DRUG METABOLISM AND DISPOSITION
- A Clinical Quantitative Evaluation of Hepatobiliary Transport of [11C]Dehydropravastatin in Humans Using Positron Emission Tomography
- (2018) Ken-ichi Kaneko et al. DRUG METABOLISM AND DISPOSITION
- Organic Anion Transporting Polypeptide 1a4 is Responsible for the Hepatic Uptake of Cardiac Glycosides in Mice
- (2018) Junichi Takano et al. DRUG METABOLISM AND DISPOSITION
- A Study on Pharmacokinetics of Bosentan with Systems Modeling, Part 1: Translating Systemic Plasma Concentration to Liver Exposure in Healthy Subjects
- (2018) Rui Li et al. DRUG METABOLISM AND DISPOSITION
- The Phenomenon of Albumin-Mediated Hepatic Uptake of Organic Anion Transport Polypeptide Substrates: Prediction of the In Vivo Uptake Clearance from the In Vitro Uptake by Isolated Hepatocytes Using a Facilitated-Dissociation Model
- (2018) Seiji Miyauchi et al. DRUG METABOLISM AND DISPOSITION
- In Vitro–In Vivo Extrapolation of OATP1B-Mediated Drug–Drug Interactions in Cynomolgus Monkey
- (2018) Ayşe Ufuk et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Organic Anion Transporter 2 Mediates Hepatic Uptake of Tolbutamide, a CYP2C9 Probe Drug
- (2018) Yi-an Bi et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Role of Hepatic Organic Anion Transporter 2 in the Pharmacokinetics of R- and S-Warfarin: In Vitro Studies and Mechanistic Evaluation
- (2018) Yi-an Bi et al. MOLECULAR PHARMACEUTICS
- Comparison of Hepatic 2D Sandwich Cultures and 3D Spheroids for Long-term Toxicity Applications: A Multicenter Study
- (2018) Catherine C Bell et al. TOXICOLOGICAL SCIENCES
- Use of physiologically-based pharmacokinetic (PBPK) modeling to evaluate the effect of chronic kidney disease on the disposition of hepatic CYP2C8 and OATP1B drug substrates
- (2018) Ming-Liang Tan et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Advancing Predictions of Tissue and Intracellular Drug Concentrations Using In Vitro , Imaging and Physiologically Based Pharmacokinetic Modeling Approaches
- (2018) Yingying Guo et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Perspective on the application of microphysiological systems to drug transporter studies
- (2018) Pedro Caetano-Pinto et al. DRUG METABOLISM AND DISPOSITION
- No Clinical Impact of CYP3A5 Gene Polymorphisms on the Pharmacokinetics and/or Efficacy of Maraviroc in Healthy Volunteers and HIV-1-Infected Subjects
- (2018) Manoli Vourvahis et al. JOURNAL OF CLINICAL PHARMACOLOGY
- Organic Anion Transporter 2 mediated Hepatic Uptake Contribute to the Clearance of High Permeability - Low Molecular Weight Acid and Zwitterion Drugs: Evaluation using 25 drugs.
- (2018) Emi Kimoto et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Extrapolation of In Vivo Hepatic Clearance from In Vitro Uptake Clearance by Suspended Human Hepatocytes for Anionic Drugs with High Binding to Human Albumin: Improvement of In Vitro-to-In Vivo Extrapolation by Considering the “Albumin-Mediated” Hepatic Uptake Mechanism on the Basis of the “Facilitated-Dissociation Model”
- (2018) Soo-Jin Kim et al. DRUG METABOLISM AND DISPOSITION
- Navigating tissue chips from development to dissemination: A pharmaceutical industry perspective
- (2017) Lorna Ewart et al. EXPERIMENTAL BIOLOGY AND MEDICINE
- Endogenous and xenobiotic metabolic stability of primary human hepatocytes in long-term 3D spheroid cultures revealed by a combination of targeted and untargeted metabolomics
- (2017) Sabine U. Vorrink et al. FASEB JOURNAL
- Hepatobiliary Clearance Prediction: Species Scaling From Monkey, Dog, and Rat, and In Vitro–In Vivo Extrapolation of Sandwich-Cultured Human Hepatocytes Using 17 Drugs
- (2017) Emi Kimoto et al. JOURNAL OF PHARMACEUTICAL SCIENCES
- In Vitro Intrinsic Permeability: A Transporter-Independent Measure of Caco-2 Cell Permeability in Drug Design and Development
- (2017) Linda Fredlund et al. MOLECULAR PHARMACEUTICS
- Functional Coupling of Human Microphysiology Systems: Intestine, Liver, Kidney Proximal Tubule, Blood-Brain Barrier and Skeletal Muscle
- (2017) Lawrence Vernetti et al. Scientific Reports
- Does the Systemic Plasma Profile Inform the Liver Profile? Analysis Using a Physiologically Based Pharmacokinetic Model and Individual Compounds
- (2016) Rui Li et al. AAPS Journal
- OCT1 mediates hepatic uptake of sumatriptan and loss-of-functionOCT1polymorphisms affect sumatriptan pharmacokinetics
- (2016) J Matthaei et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Transport vs. Metabolism: What Determines the Pharmacokinetics and Pharmacodynamics of Drugs? Insights From the Extended Clearance Model
- (2016) G Patilea-Vrana et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Liver and Kidney on Chips: Microphysiological Models to Understand Transporter Function
- (2016) SY Chang et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Transporter-Mediated Hepatic Uptake Plays an Important Role in the Pharmacokinetics and Drug-Drug Interactions of Montelukast
- (2016) MV Varma et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Quantitative Analyses of Hepatic OATP-Mediated Interactions Between Statins and Inhibitors Using PBPK Modeling With a Parameter Optimization Method
- (2016) T Yoshikado et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Organic Anion Transporter 2: An Enigmatic Human Solute Carrier
- (2016) Hong Shen et al. DRUG METABOLISM AND DISPOSITION
- The impact of Organic Anion-Transporting Polypeptides (OATPs) on disposition and toxicity of antitumor drugs: Insights from knockout and humanized mice
- (2016) Selvi Durmus et al. DRUG RESISTANCE UPDATES
- CYP2C9 Genotype-Dependent Warfarin Pharmacokinetics: Impact of CYP2C9 Genotype on R- and S-Warfarin and Their Oxidative Metabolites
- (2016) Darcy R. Flora et al. JOURNAL OF CLINICAL PHARMACOLOGY
- In Vivo Imaging of Human 11C-Metformin in Peripheral Organs: Dosimetry, Biodistribution, and Kinetic Analyses
- (2016) L. C. Gormsen et al. JOURNAL OF NUCLEAR MEDICINE
- Loss-of-function polymorphisms in the organic cation transporter OCT1 are associated with reduced postoperative tramadol consumption
- (2016) Ulrike M. Stamer et al. PAIN
- Projecting ADME Behavior and Drug-Drug Interactions in Early Discovery and Development: Application of the Extended Clearance Classification System
- (2016) Ayman F. El-Kattan et al. PHARMACEUTICAL RESEARCH
- Effects of Cytochrome P450 Inhibition and Induction on the Phenotyping Metrics of the Basel Cocktail: A Randomized Crossover Study
- (2015) Adrian Derungs et al. CLINICAL PHARMACOKINETICS
- Mechanistic understanding of the nonlinear pharmacokinetics and intersubject variability of simeprevir: A PBPK-guided drug development approach
- (2015) J Snoeys et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Physiologically based pharmacokinetic modeling in drug discovery and development: A pharmaceutical industry perspective
- (2015) HM Jones et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- A human liver microphysiology platform for investigating physiology, drug safety, and disease models
- (2015) Lawrence A Vernetti et al. EXPERIMENTAL BIOLOGY AND MEDICINE
- Albumin and Uptake of Drugs in Cells: Additional Validation Exercises of a Recently Published Equation that Quantifies the Albumin-Facilitated Uptake Mechanism(s) in Physiologically Based Pharmacokinetic and Pharmacodynamic Modeling Research
- (2015) Patrick Poulin et al. JOURNAL OF PHARMACEUTICAL SCIENCES
- Predicting Clearance Mechanism in Drug Discovery: Extended Clearance Classification System (ECCS)
- (2015) Manthena V. Varma et al. PHARMACEUTICAL RESEARCH
- SLCO1B1 polymorphism markedly affects the pharmacokinetics of lovastatin acid
- (2015) Aleksi Tornio et al. Pharmacogenetics and Genomics
- Drug-Drug Interaction Potentials of Tyrosine Kinase Inhibitors via Inhibition of UDP-Glucuronosyltransferases
- (2015) Nan Zhang et al. Scientific Reports
- A New PAMPA Model Proposed on the Basis of a Synthetic Phospholipid Membrane
- (2015) Hui Yu et al. PLoS One
- Mechanism-Based Pharmacokinetic Modeling to Evaluate Transporter-Enzyme Interplay in Drug Interactions and Pharmacogenetics of Glyburide
- (2014) Manthena V. S. Varma et al. AAPS Journal
- Pitavastatin is a more sensitive and selective organic anion-transporting polypeptide 1B clinical probe than rosuvastatin
- (2014) Thomayant Prueksaritanont et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Prediction of Pharmacokinetics and Drug–Drug Interactions When Hepatic Transporters are Involved
- (2014) Rui Li et al. CLINICAL PHARMACOKINETICS
- Predicting carrier-mediated hepatic disposition of rosuvastatin in man by scaling from individual transfected cell-lines in vitro using absolute transporter protein quantification and PBPK modeling
- (2014) Sieto Bosgra et al. EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES
- A “middle-out” approach to human pharmacokinetic predictions for OATP substrates using physiologically-based pharmacokinetic modeling
- (2014) Rui Li et al. JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS
- Microfluidic organs-on-chips
- (2014) Sangeeta N Bhatia et al. NATURE BIOTECHNOLOGY
- Morphological behaviour and metabolic capacity of cryopreserved human primary hepatocytes cultivated in a perfused multiwell device
- (2014) Aurelie Vivares et al. XENOBIOTICA
- Exploring BSEP inhibition-mediated toxicity with a mechanistic model of drug-induced liver injury
- (2014) Jeffrey L. Woodhead et al. Frontiers in Pharmacology
- Role of Hepatic Efflux Transporters in Regulating Systemic and Hepatocyte Exposure to Xenobiotics
- (2013) Nathan D. Pfeifer et al. Annual Review of Pharmacology and Toxicology
- A Mechanistic Framework for In Vitro–In Vivo Extrapolation of Liver Membrane Transporters: Prediction of Drug–Drug Interaction Between Rosuvastatin and Cyclosporine
- (2013) M. Jamei et al. CLINICAL PHARMACOKINETICS
- The UDP-glucuronosyltransferases: Their role in drug metabolism and detoxification
- (2013) Andrew Rowland et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- The Effects of Boceprevir and Telaprevir on the Pharmacokinetics of Maraviroc
- (2013) Manoli Vourvahis et al. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
- OCT1 genetic variants influence the pharmacokinetics of morphine in children
- (2013) Tsuyoshi Fukuda et al. PHARMACOGENOMICS
- Functional characterization of 32 CYP2C9 allelic variants
- (2013) Y Niinuma et al. PHARMACOGENOMICS JOURNAL
- Dissecting the relative contribution of OATP1B1-mediated uptake of xenobiotics into human hepatocytes using siRNA
- (2013) B. Williamson et al. XENOBIOTICA
- Hepatic and Intestinal Drug Transporters: Prediction of Pharmacokinetic Effects Caused by Drug-Drug Interactions and Genetic Polymorphisms
- (2012) Kenta Yoshida et al. Annual Review of Pharmacology and Toxicology
- Predicting human hepatic clearance from in vitro drug metabolism and transport data: a scientific and pharmaceutical perspective for assessing drug-drug interactions
- (2012) Gian Camenisch et al. BIOPHARMACEUTICS & DRUG DISPOSITION
- Clinical significance of organic anion transporting polypeptides (OATPs) in drug disposition: their roles in hepatic clearance and intestinal absorption
- (2012) Yoshihisa Shitara et al. BIOPHARMACEUTICS & DRUG DISPOSITION
- Influence of Human OATP1B1, OATP1B3, and OATP1A2 on the Pharmacokinetics of Methotrexate and Paclitaxel in Humanized Transgenic Mice
- (2012) E. van de Steeg et al. CLINICAL CANCER RESEARCH
- Species differences in drug transporters and implications for translating preclinical findings to humans
- (2012) Xiaoyan Chu et al. Expert Opinion on Drug Metabolism & Toxicology
- Characterization of Organic Anion Transporting Polypeptide (OATP) Expression and Its Functional Contribution to the Uptake of Substrates in Human Hepatocytes
- (2012) Emi Kimoto et al. MOLECULAR PHARMACEUTICS
- pH-Dependent Solubility and Permeability Criteria for Provisional Biopharmaceutics Classification (BCS and BDDCS) in Early Drug Discovery
- (2012) Manthena V. Varma et al. MOLECULAR PHARMACEUTICS
- Physiologically Based Modeling of Pravastatin Transporter-Mediated Hepatobiliary Disposition and Drug-Drug Interactions
- (2012) Manthena V. S. Varma et al. PHARMACEUTICAL RESEARCH
- Cyclosporine Inhibition of Hepatic and Intestinal CYP3A4, Uptake and Efflux Transporters: Application of PBPK Modeling in the Assessment of Drug-Drug Interaction Potential
- (2012) Michael Gertz et al. PHARMACEUTICAL RESEARCH
- A new approach to predicting human hepatic clearance of CYP3A4 substrates using monkey pharmacokinetic data
- (2012) Kotaro Ogawa et al. XENOBIOTICA
- The reconstituted ‘humanized liver’ in TK-NOG mice is mature and functional
- (2011) Masami Hasegawa et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Identification of the Rate-Determining Process in the Hepatic Clearance of Atorvastatin in a Clinical Cassette Microdosing Study
- (2011) K Maeda et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Effects of SLCO1B1 and ABCB1 genotypes on the pharmacokinetics of atorvastatin and 2-hydroxyatorvastatin in healthy Korean subjects
- (2011) Y.J. Lee et al. INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS
- Development of a new permeability assay using low‐efflux MDCKII cells
- (2011) Li Di et al. JOURNAL OF PHARMACEUTICAL SCIENCES
- The pharmacogenetics of metformin and its impact on plasma metformin steady-state levels and glycosylated hemoglobin A1c
- (2011) Mette M.H. Christensen et al. Pharmacogenetics and Genomics
- Organic Anion Transporting Polypeptide 1B1: a Genetically Polymorphic Transporter of Major Importance for Hepatic Drug Uptake
- (2011) M. Niemi et al. PHARMACOLOGICAL REVIEWS
- Cyclosporine A, but Not Tacrolimus, Shows Relevant Inhibition of Organic Anion-Transporting Protein 1B1-Mediated Transport of Atorvastatin
- (2010) R. Amundsen et al. DRUG METABOLISM AND DISPOSITION
- Sandwich-cultured hepatocytes: anin vitromodel to evaluate hepatobiliary transporter-based drug interactions and hepatotoxicity
- (2010) Brandon Swift* et al. DRUG METABOLISM REVIEWS
- Organic anion transporting polypeptide 1a/1b–knockout mice provide insights into hepatic handling of bilirubin, bile acids, and drugs
- (2010) Evita van de Steeg et al. JOURNAL OF CLINICAL INVESTIGATION
- Membrane transporters in drug development
- (2010) NATURE REVIEWS DRUG DISCOVERY
- Effects of OCT1 polymorphisms on the cellular uptake, plasma concentrations and efficacy of the 5-HT3 antagonists tropisetron and ondansetron
- (2010) M V Tzvetkov et al. PHARMACOGENOMICS JOURNAL
- A Comparison of Pharmacokinetics between Humans and Monkeys
- (2009) T. Akabane et al. DRUG METABOLISM AND DISPOSITION
- Investigation of the Rate-Determining Process in the Hepatic Elimination of HMG-CoA Reductase Inhibitors in Rats and Humans
- (2009) T. Watanabe et al. DRUG METABOLISM AND DISPOSITION
- Voriconazole Increases while Itraconazole Decreases Plasma Meloxicam Concentrations
- (2008) V. V. Hynninen et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Effects of CYP3A4 inhibitors on the pharmacokinetics of maraviroc in healthy volunteers
- (2008) Samantha Abel et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- The effect ofSLCO1B1polymorphism on repaglinide pharmacokinetics persists over a wide dose range
- (2008) Annikka Kalliokoski et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Elucidating Rifampin's Inducing and Inhibiting Effects on Glyburide Pharmacokinetics and Blood Glucose in Healthy Volunteers: Unmasking the Differential Effects of Enzyme Induction and Transporter Inhibition for a Drug and Its Primary Metabolite
- (2008) HX Zheng et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Involvement of Multiple Transporters in the Hepatobiliary Transport of Rosuvastatin
- (2008) S. Kitamura et al. DRUG METABOLISM AND DISPOSITION
- Physiologically Based Pharmacokinetic Modeling to Predict Transporter-Mediated Clearance and Distribution of Pravastatin in Humans
- (2008) T. Watanabe et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More